Target intelligence / Profile preview

ACTN3 antisense RNA 1 (ACTN3-AS1)

Target
ACTN3-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA (NAT, natural antisense transcript), Non-coding RNA
01

Overview

ACTN3 antisense RNA 1 (ACTN3-AS1) is a long non-coding RNA transcribed from the genome in the region antisense to the *ACTN3* gene. Antisense RNAs such as ACTN3-AS1 can regulate the expression of their sense counterparts at the level of transcription or translation. While regulation by antisense RNA is well-described in various systems, specific data on ACTN3-AS1’s biological function, disease association, or druggability is limited to database entries and general knowledge of antisense mechanisms. As a non-coding RNA, ACTN3-AS1 is fundamentally different from a typical drug target (like a receptor or enzyme) and mainly functions in gene expression regulation, potentially affecting the expression or processing of ACTN3 mRNA, but its therapeutic relevance remains largely unexplored. ACTN3-AS1 is correctly identified as a non-coding antisense RNA. It is not an established therapeutic target and has no direct drug interactions known. Its main role is gene regulation; specific roles in disease or therapy are not described in current literature.

Other names
ACTN3-AS1ACTN3 Antisense RNA 1
02

Mechanism of action

Acts by non-coding RNA-based regulation of gene expression, not as a receptor, enzyme, or protein

03

Biological functions

Regulation of gene expression, especially of the ACTN3 gene via antisense mechanismsPossible involvement in cis- or trans- regulation of the ACTN3 locus
04

Disease associations

Unknown/Not well established for ACTN3-AS1 specifically. However, antisense RNAs can impact diseases through gene regulation; ACTN3 itself is linked to muscle performance and muscle wasting, but not ACTN3-AS1 directly

Beyond the preview

Go deeper on ACTN3 antisense RNA 1 (ACTN3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACTN3 antisense RNA 1 (ACTN3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call